Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2385-2390

  Kogure, Takahisa ^a   Shimada, Reona ^a   Ishikawa, Jun ^b   Yazawa, Katsukiyo ^a   Brown, June M ^c   Mikami, Yuzuru ^a   Gonoi, Tohru ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; APRAMYCIN; FORTIMICIN; GENTAMICIN; HABEKACIN; HYGROMYCIN B; ISEPAMICIN; KANAMYCIN; NEOMYCIN; NETILMICIN; PAROMOMYCIN; RIBOSTAMYCIN; RNA 16S; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CANADA; CATTLE DISEASE; CHROMOSOME; CROSS RESISTANCE; DNA SEQUENCE; DRUG SENSITIVITY; ESCHERICHIA COLI; GENE MUTATION; MOLECULAR CLONING; NOCARDIA FARCINICA; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMIKACIN; AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CANADA; CATTLE; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HOMOZYGOTE; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; NOCARDIA; NOCARDIA INFECTIONS; POINT MUTATION; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S;

EID: 77952647311     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00021-10     Document Type: Article

References (29)

1. Alangaden, G. J., B. N. Kreiswirth, A. Aouad, M. Khetarpal, F. R. Igno, S. L. Moghazeh, E. K. Manavathu, and S. A. Lerner. 1998. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1295-1297.
2. Beauclerk, A. A., and E. Cundliffe. 1987. Sites of action of two rRNA methylases responsible for resistance to aminoglycosides. J. Mol. Biol. 193: 661-671.
3. Besier, S., A. Ludwig, J. Zander, V. Brade, and T. A. Wichelhaus. 2008. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob. Agents Chemother. 52:1570-1572.
4. Brown, J. M., K. D. Cowley, K. I. Manninen, and M. M. McNeil. 2007. Phenotypic and molecular epidemiologic evaluation of a Nocardia farcinica mastitis epizootic. Vet. Microbiol. 125:66-72.
5. Brown-Elliott, B. A., J. M. Brown, P. S. Conville, and R. J. Wallace, Jr. 2006. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19:259-282.
6. Chiba, K., Y. Hoshino, K. Ishino, T. Kogure, Y. Mikami, Y. Uehara, and J. Ishikawa. 2007. Construction of a pair of practical Nocardia-Escherichia coli shuttle vectors. Jpn. J. Infect. Dis. 60:45-47.
7. Doi, Y., K. Yokoyama, K. Yamane, J. Wachino, N. Shibata, T. Yagi, K. Shibayama, H. Kato, and Y. Arakawa. 2004. Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob. Agents Chemother. 48:491-496.
8. Ferns, L., I. Dohoo, and A. Donald. 1991. A case-control study of Nocardia mastitis in Nova Scotia dairy herds. Can. Vet. J. 32:673-677.
9. Fourmy, D., M. I. Recht, S. C. Blanchard, and J. D. Puglisi. 1996. Structure of the A site of Escherichia coli 16S rRNA complexed with an aminoglycoside antibiotic. Science 274:1367-1371. (Pubitemid 26391459)
10. Galimand, M., P. Courvalin, and T. Lambert. 2003. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob. Agents Chemother. 47:2565-2571.
11. Gonzalez-Escalona, N., J. Romero, and R. T. Espejo. 2005. Polymorphism and gene conversion of the 16S rRNA genes in the multiple rRNA operons of Vibrio parahaemolyticus. FEMS. Microbiol. Lett. 246:213-219.
12. Hashimoto, J. G., B. S. Stevenson, and T. M. Schmidt. 2003. Rates and consequences of recombination between rRNA operons. J. Bacteriol. 185: 966-972.
13. Hitti, W., and M. Wolff. 2005. Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy. Eur. J. Clin. Microbiol. Infect. Dis. 24:142-144.
14. Ishikawa, J., K. Chiba, H. Kurita, and H. Satoh. 2006. Contribution of rpoB2 RNA polymerase beta subunit gene to rifampin resistance in Nocardia species. Antimicrob. Agents Chemother. 50:1342-1346.
15. Ishikawa, J., A. Yamashita, Y. Mikami, Y. Hoshino, H. Kurita, K. Hotta, T. Shiba, and M. Hattori. 2004. The complete genomic sequence of Nocardia farcinica IFM 10152. Proc. Natl. Acad. Sci. U. S. A. 101:14925-14930.
16. Kageyama, A., K. Yazawa, J. Ishikawa, K. Hotta, K. Nishimura, and Y. Mikami. 2004. Nocardial infections in Japan from 1992 to 2001, including the first report of infection by Nocardia transvalensis. Eur. J. Epidemiol. 19:383-389.
17. Liao, D. 2000. Gene conversion drives within genic sequences: concerted evolution of rRNA genes in bacteria and archaea. J. Mol. Evol. 51:305-317.
18. Manninen, K. I., R. A. Smith, and L. O. Kim. 1993. Highly presumptive identification of bacterial isolates associated with the recent Canada-wide mastitis epizootic as Nocardia farcinica. Can. J. Microbiol. 39:635-641.
19. Mingeot-Leclercq, M. P., Y. Glupczynski, and P. M. Tulkens. 1999. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727-737.
20. Moazed, D., and H. F. Noller. 1987. Interaction of antibiotics with functional sites in 16S rRNA. Nature 327:389-394. (Pubitemid 17075811)
21. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
22. Ollis, G. W., M. Schoonderwoerd, and C. Schipper. 1991. An investigation of risk factors for nocardial mastitis in central Alberta dairy herds. Can. Vet. J. 32:227-231.
23. Prammananan, T., P. Sander, B. A. Brown, K. Frischkorn, G. O. Onyi, Y. Zhang, E. C. Bottger, and R. J. Wallace, Jr. 1998. A single 16S rRNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J. Infect. Dis. 177:1573-1581.
24. Prammananan, T., P. Sander, B. Springer, and E. C. Bottger. 1999. RecA-Mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob. Agents Chemother. 43:447-453.
25. Recht, M. I., S. Douthwaite, and J. D. Puglisi. 1999. Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J. 18:3133-3138.
26. Russo, T. A. 2005. Agents of actinomycosis, p. 2924-2934. In G. L. Mandell, Bennette, J. E., Dolin, R (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed., vol.2. Elsevier, New York, NY.
27. Sander, P., T. Prammananan, and E. C. Bottger. 1996. Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol. Microbiol. 22:841-848.
28. Stark, D. A., and N. G. Anderson. 1990. A case-control study of Nocardia mastitis in Ontario dairy herds. Can. Vet. J. 31:197-201.
29. Yokoyama, K., Y. Doi, K. Yamane, H. Kurokawa, N. Shibata, K. Shibayama, T. Yagi, H. Kato, and Y. Arakawa. 2003. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 362:1888-1893. (Pubitemid 37518504)